OriCiro Genomics

About:

OriCiro Genomics develops and commercializes cell-free synthesis and amplification technologies of large DNA molecules.

Website: https://oriciro.com/

Twitter/X: oricirog

Top Investors: Japan Finance Corporation, UTEC - The University of Tokyo Edge Capital Partners, Asahi Kasei, ITOCHU Technology Ventures

Description:

OriCiro Genomics creates a better bioeconomy with innovative genome technologies. The company is a pioneer in cell-free synthesis and amplification of genome-scale large DNA for synthetic biology. The company creates a technology that covers "DNA assembly" and "circular DNA amplification", allowing to construct large circular DNA molecules without relying on conventional biological cloning.